Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Glaxo Operations UK Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom Trading as GlaxoSmithKline UK
Fortum 1 g powder for solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection or infusion. Vials containing white to cream sterile powder. |
Each vial contains 1 g ceftazidime (as pentahydrate) with sodium carbonate (118 mg per gram of ceftazidime).
Excipient with known effect:
Each vial contains 52 mg (2.3 mmol) of sodium per vial.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ceftazidime |
Ceftazidime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. |
| List of Excipients |
|---|
|
Sodium carbonate (anhydrous sterile) |
Fortum 1 g powder for solution for injection or infusion is packaged in clear Ph.Eur.Type III glass 17 ml, 26 ml, 60 ml or 77 ml vial with a bromobutyl rubber plug and a flip-off type aluminium overseal.
Packs of 1, 5, 10, 50 or 100 vials.
Not all pack sizes may be marketed.
Glaxo Operations UK Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Trading as
GlaxoSmithKline UK
PL 00004/0293
Date of first authorisation: 17 October 1983
Date of latest renewal: 17 January 2011
| Drug | Countries | |
|---|---|---|
| FORTUM | Austria, Cyprus, Estonia, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, New Zealand, Poland, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
